T. Kylmälä

发表

Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancer

T. Tammela, K. Rantakokko-jalava, R. Manninen, 2003, The Prostate.

Suspicious Urine Cytology (Class III) in Patients with Bladder Cancer: Should it be Considered as Negative or Positive?

H. Huhtala, E. Kaasinen, M. Raitanen, 2002, Scandinavian journal of urology and nephrology.

The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study.

T. Tammela, C. Lamberg-Allardt, I. Elomaa, 1994, European journal of cancer.

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.

T. Tammela, J. Risteli, I. Elomaa, 1995, British Journal of Cancer.

Treatment of postoperative male urinary incontinence using transurethral macroplastique injections.

T. Tammela, M. Raitanen, H. Tainio, 2003, Journal of endourology.

Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years

T. Tammela, J. Johansson, P. Klarskov, 2006, Scandinavian journal of urology and nephrology.

Study of tyrosine hydroxylase and neuropeptidergic innervation of the human obstructed pelveoureteral junction in four different patients.

H. Tainio, T. Kylmälä, K. Järvilehto, 1993, Acta histochemica.

The dilemma of suspicious urine cytology in patients being followed for bladder cancer.

M. Raitanen, R. Aine, J. Kallio, 2001, Annales chirurgiae et gynaecologiae.

The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.

T. Tammela, T. Lindholm, T. Kylmälä, 1994, Annales chirurgiae et gynaecologiae.

Peptidergic innervation of the normal and obstructed human pyeloureteral junctions.

H. Tainio, T. Kylmälä, A. Heikkinen, 1992, Urologia internationalis.

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group.

T. Tammela, J. Risteli, I. Elomaa, 1993, European journal of cancer.

Effect of oral clodronate on bone pain

T. Tammela, K. Jauhiainen, O. Alfthan, 1992, International Urology and Nephrology.

Side-fenestrated catheter decreases leakage at the urethrovesical anastomosis after robot-assisted laparoscopic radical prostatectomy

M. Matikainen, J. Riikonen, A. Kaipia, 2014, Scandinavian journal of urology.

Effect of concomitant administration of clodronate and estramustine phosphate on their bioavailability in patients with metastasized prostate cancer.

T. Tammela, P. Ylitalo, T. Kylmälä, 1996, Pharmacology & toxicology.

Primary malignant melanoma of the urinary bladder associated with widespread metastases.

H. Haapasalo, H. Tainio, T. Kylmälä, 1999, Scandinavian journal of urology and nephrology.